Thermalin

About:

Thermalin offers insulins and delivery systems that transform the economic, treatment, and disease management paradigms for diabetes.

Website: http://www.thermalin.com

Top Investors: Sanofi, JumpStart, Robin Hood Ventures, Jumpstart Ventures, Green Park & Golf Ventures

Description:

Thermalin hopes to disrupt the $30B insulin/insulin delivery market with a disposable, postage-stamp-sized glucose management system enabled by our first-in-class stabilized, highly concentrated, and ultra-rapid acting insulin. This same new insulin molecule in "ordinary" (U-100) concentration will enable the factory-filling of reservoirs for existing insulin pumps. In addition to this lead program, Thermalin is developing partnerships on no-cold-chain basal and mix insulins and on glucose-responsive insulins.

Total Funding Amount:

$37.6M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Cleveland, Ohio, United States

Founded Date:

2010-01-01

Contact Email:

rick(AT)thermalin.com

Founders:

Michael Weiss, Richard Berenson

Number of Employees:

11-50

Last Funding Date:

2022-08-18

IPO Status:

Private

Industries:

© 2025 bioDAO.ai